| Patient | Samuel Langhorne Clemens |
|---|---|
| Date of birth | 1956-11-30 |
| Identifiers | MRN HR-NI013-SYN; SSN (made up) 000-13-2964 |
| Document date | 2026-09-11 |
| Author | Winifred Achterberg-Lowe, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Thirteen-week review: grief therapy, smoking, a gout flare while away, urate and lipids. [S]
Mr. Clemens returns eight weeks after his five-week review, after nearly three weeks away in August. Two days after he left, his right big toe became hot, swollen and too painful to walk on; a doctor where he was staying prescribed prednisone 40 mg for five days, and he kept taking allopurinol and colchicine as told. The flare settled within a week. Because he was away, the urate test planned three to four weeks after starting allopurinol was not done until today. He stopped smoking on his quit date at the start of August, smoked two cigars one evening while away, and none since; varenicline causes mild nausea only. His bronchitis from the sick visit has cleared. He has had eleven grief therapy sessions, two of them by telephone while away; he missed one. He sleeps about six hours, writes most mornings and has begun to see friends. No chest tightness. [S]
| Element | Detail |
|---|---|
| Gout | A flare while away, treated with prednisone; allopurinol continued |
| Tobacco | Quit at the start of August; one lapse of two cigars; none for three weeks |
| Grief therapy | Eleven sessions, two by telephone; PG-13-R 32 |
| Chest | No tightness since July |
| Results today | Urate 7.4 mg/dL; LDL 74 mg/dL; ALT 28 U/L; creatinine 1.10 mg/dL |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy better; weight up |
| Cardiovascular | Negative | No chest tightness |
| Musculoskeletal | Negative | Toe recovered; no muscle aches |
| Psychiatric | Positive | Grief easing; no thoughts of death |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Varenicline 0.5 mg oral tablet: one tablet daily for three days, then one tablet twice daily for four days | One tablet daily on days 1 to 3, then twice daily on days 4 to 7 | Oral route | 2026-07-17 to 2026-07-24 | completed | S |
| Varenicline 1 mg oral tablet, one tablet twice daily with food for twelve weeks, with a quit date in the second week | One tablet twice daily with food | Oral route | 2026-07-24 | active | S |
| Atorvastatin 40 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-07-17 | active | S |
| Aspirin 81 mg delayed-release oral tablet, one tablet daily | One tablet daily | Oral route | 2026-07-17 | active | S |
| Allopurinol 100 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-07-17 to 2026-09-11 | completed | S |
| Allopurinol 100 mg oral tablet, two tablets daily (200 mg) | Two tablets daily | Oral route | 2026-09-11 to 2026-10-16 | completed | S |
| Colchicine 0.6 mg oral tablet, one tablet daily for flare prevention while allopurinol is started, for three to six months | One tablet daily | Oral route | 2026-07-17 | active | S |
| Prednisone 20 mg oral tablet, two tablets (40 mg) each morning for five days, for a gout flare, prescribed by a doctor where he was staying | Two tablets each morning for five days | Oral route | 2026-08-12 to 2026-08-16 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-09-11 | Body height | 173 | cm | S |
| 2026-09-11 | Body weight | 64.9 | kg | S |
| 2026-09-11 | Body mass index (BMI) [Ratio] | 21.7 | kg/m2 | S |
| 2026-09-11 | Systolic blood pressure | 130 | mm[Hg] | S |
| 2026-09-11 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-09-11 | Heart rate | 72 | /min | S |
| 2026-09-11 | Respiratory rate | 14 | /min | S |
| 2026-09-11 | Body temperature | 36.6 | Cel | S |
| 2026-09-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-09-11 | Cholesterol [Mass/volume] in Serum or Plasma | 156 | mg/dL | <=199 mg/dL | Normal | S |
| 2026-09-11 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 46 | mg/dL | >=40 mg/dL | Normal | S |
| 2026-09-11 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 74 | mg/dL | <=99 mg/dL | Normal | S |
| 2026-09-11 | Triglyceride [Mass/volume] in Serum or Plasma | 180 | mg/dL | <=149 mg/dL | High | S |
| 2026-09-11 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 28 | U/L | 7-56 U/L | Normal | S |
| 2026-09-11 | Urate [Mass/volume] in Serum or Plasma | 7.4 | mg/dL | 3.5-7.2 mg/dL | High | S |
| 2026-09-11 | Sodium [Moles/volume] in Serum or Plasma | 139 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-09-11 | Potassium [Moles/volume] in Serum or Plasma | 4.5 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-09-11 | Creatinine [Mass/volume] in Serum or Plasma | 1.1 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-09-11 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 73 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-09-11 | Glucose [Mass/volume] in Serum or Plasma | 98 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-09-11 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | {score} | S |
Vital signs recorded on 2026-09-11; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 130/78, pulse 72; weight 64.9 kg |
| Respiratory | Clear |
| Musculoskeletal | Right first toe joint normal; no tophi |
| Psychiatric | Engaged and humorous; speaks of his wife with less pain |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Persistent yearning for his wife, broken sleep, low mood and withdrawal from friends and work, a year after her death; cause under evaluation | resolved | confirmed | Z63.4 | S — Synthetic presenting problem anchored to his wife's documented death a year before; resolved into the diagnosis of prolonged grief disorder at the consultation. Not a claim about his real grief. |
| Prolonged grief disorder (DSM-5-TR): more than 12 months after his wife's death, daily yearning and preoccupation with her, with intense emotional pain, a sense that part of himself has died, avoidance of reminders, loneliness, difficulty taking up his work and life again, and a feeling that life is meaningless; PG-13-R 41; major depression not present | active | confirmed | F43.81 | S — Synthetic modern diagnosis made at the consultation, anchored to his documented bereavements. Not a claim about his real mental health; the roster's bipolar lead is not used. |
| Tobacco use disorder, cigars: about fifteen cigars a day, smoking since boyhood, some smoke inhaled; first cigar within thirty minutes of waking | active | confirmed | F17.290 | S — Synthetic modern coding anchored to his documented smoking since boyhood. |
| Chest tightness on climbing steep hills, twice in the past month, easing within five minutes of rest; none at rest; cause under evaluation | resolved | confirmed | R07.89 | S — Synthetic presenting symptom; resolved into a diagnosis at five weeks after CT coronary angiography. Not a claim about his real heart in 1905; his documented chest pain began in 1909. |
| Coronary artery disease, nonobstructive (CAD-RADS 2: 25 to 49 percent narrowing of the proximal left anterior descending artery; coronary calcium score 410), with exertional chest tightness that has not recurred on treatment; treated with a statin, aspirin and stopping smoking | active | confirmed | I25.10 | S — Synthetic modern diagnosis made at five weeks. Not a claim about his real coronary arteries. |
| Gout, recurrent flares of the big toe since his late fifties, two in the past year; serum urate 8.6 mg/dL; no tophi | active | confirmed | M10.9 | S — Synthetic modern diagnosis anchored to his documented gout. |
| Acute bronchitis, likely viral, for six days in a cigar smoker; no pneumonia on examination; resolved within three weeks without antibiotics | resolved | confirmed | J20.9 | S — Synthetic acute illness; not a historical claim; his documented bronchitis was in later years. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Grief severity (PG-13-R) and the DSM-5-TR prolonged grief disorder criteria | At diagnosis and every four weeks during therapy | Completed today | PG-13-R 32 |
| Referral | Prolonged grief disorder therapy: sessions attended | Weekly for sixteen weeks | Completed today | Eleven sessions, two by telephone while away; one missed |
| Survey | Depression (PHQ-9), to watch for major depression | At baseline and every four weeks during treatment | Completed today | PHQ-9 7, item 9 scored 0 |
| Survey | Suicide risk review, safety plan, means safety and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of death; safety plan kept |
| Self-management | Sleep, without sedative-hypnotics | Every visit | Completed today | About six hours |
| Self-management | Social contact and his writing | Every visit | Completed today | Writing most mornings; seeing friends weekly |
| Self-management | Tobacco use (cigars a day), readiness and counseling | Every visit | Completed today | No cigars for three weeks after one lapse |
| Medication safety | Varenicline: adherence, nausea, sleep and mood changes | Every visit | Completed today | Mild nausea only; no change in mood or sleep from varenicline |
| Examination | Chest symptoms on exertion | Every visit | Completed today | None since July |
| Examination | Blood pressure | Every visit | Completed today | 130/78 mmHg |
| Laboratory | Lipid panel and ALT on a statin | 4 to 12 weeks after starting, then every 3 to 12 months | Completed today | Eight weeks on atorvastatin: total cholesterol 156, HDL 46, LDL 74 (51 percent lower), triglycerides 180 mg/dL; ALT 28 U/L |
| Medication safety | Aspirin and statin adherence, bleeding and muscle symptoms | Every visit | Completed today | Taking both daily; no bleeding or muscle aches |
| Laboratory | Serum urate during allopurinol titration | Every 2 to 5 weeks while titrating, then every 6 months | Deferred | The check due three to four weeks after starting allopurinol was missed while he was away, which delayed the first dose increase by about four weeks; a flare occurred in that time, but flares are common early in treatment and he had no lasting harm. Today 7.4 mg/dL. Corrective action: urate four to five weeks after each change at a laboratory near wherever he is staying |
| Self-management | Gout flares and colchicine prophylaxis | Every visit | Completed today | One flare in August treated with prednisone while away; allopurinol and colchicine continued |
| Laboratory | Kidney function on allopurinol and colchicine | With each urate check | Completed today | Sodium 139, potassium 4.5 mmol/L, creatinine 1.10 mg/dL, eGFR 73, glucose 98 mg/dL |
Goal progress:
Guideline basis: Prolonged Grief Disorder (DSM-5-TR criteria, patient and family information) (2022); Validation of the new DSM-5-TR criteria for prolonged grief disorder and the PG-13-Revised (PG-13-R) scale (2021); Treatment of complicated grief: a randomized controlled trial (2005); Optimizing Treatment of Complicated Grief: A Randomized Clinical Trial (2016); Loss of partner and suicide risks among oldest old: a population-based register study (2004); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain (2021); 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2020 American College of Rheumatology Guideline for the Management of Gout (2020); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease, hyperlipidemia, and depression, bipolar, and mood disorders monographs (2026)
Follow-up: Annual wellness visit in two weeks. Eighteen-week review in five weeks with a urate test. Call the clinic or 988 at any time. Next scheduled visit 2026-09-25: subsequent annual wellness visit. [S]